Logo image of OBCI

OCEAN BIO-CHEM INC (OBCI) Stock Fundamental Analysis

NASDAQ:OBCI - Nasdaq - US6746311066 - Common Stock - Currency: USD

13.03  -0.01 (-0.08%)

After market: 13.07 +0.04 (+0.31%)

Fundamental Rating

2

Overall OBCI gets a fundamental rating of 2 out of 10. We evaluated OBCI against 12 industry peers in the Household Products industry. The financial health of OBCI is average, but there are quite some concerns on its profitability. OBCI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

OBCI had positive earnings in the past year.
OBCI Yearly Net Income VS EBIT VS OCF VS FCFOBCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 12.58%
ROE 16.11%
ROIC 13.99%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OBCI Yearly ROA, ROE, ROICOBCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15 20

1.3 Margins

Industry RankSector Rank
OM 15.74%
PM (TTM) 12.2%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OBCI Yearly Profit, Operating, Gross MarginsOBCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so OBCI is creating value.
Compared to 1 year ago, OBCI has more shares outstanding
Compared to 1 year ago, OBCI has a worse debt to assets ratio.
OBCI Yearly Shares OutstandingOBCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M
OBCI Yearly Total Debt VS Total AssetsOBCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

An Altman-Z score of 8.61 indicates that OBCI is not in any danger for bankruptcy at the moment.
OBCI has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 8.61
ROIC/WACC1.92
WACC7.29%
OBCI Yearly LT Debt VS Equity VS FCFOBCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 7.74 indicates that OBCI has no problem at all paying its short term obligations.
A Quick Ratio of 4.14 indicates that OBCI has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 7.74
Quick Ratio 4.14
OBCI Yearly Current Assets VS Current LiabilitesOBCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

3

3. Growth

3.1 Past

OBCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.57%.
Measured over the past years, OBCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.75% on average per year.
Looking at the last year, OBCI shows a small growth in Revenue. The Revenue has grown by 4.99% in the last year.
Measured over the past years, OBCI shows a quite strong growth in Revenue. The Revenue has been growing by 12.17% on average per year.
EPS 1Y (TTM)-28.57%
EPS 3Y43.4%
EPS 5Y30.75%
EPS Q2Q%-31.83%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y15.44%
Revenue growth 5Y12.17%
Sales Q2Q%-2.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OBCI Yearly Revenue VS EstimatesOBCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.89, OBCI is valued correctly.
OBCI is valuated rather cheaply when we compare the Price/Earnings ratio to 27.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.89
Fwd PE N/A
OBCI Price Earnings VS Forward Price EarningsOBCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.52
OBCI Per share dataOBCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.52
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

OBCI has a Yearly Dividend Yield of 1.23%. Purely for dividend investing, there may be better candidates out there.
Compared to an average S&P500 Dividend Yield of 2.35, OBCI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.23%

5.2 History

OBCI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
OBCI Yearly Dividends per shareOBCI Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

15.89% of the earnings are spent on dividend by OBCI. This is a low number and sustainable payout ratio.
DP15.89%
EPS Next 2YN/A
EPS Next 3YN/A
OBCI Yearly Income VS Free CF VS DividendOBCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 2M -2M 4M 6M 8M
OBCI Dividend Payout.OBCI Dividend Payout, showing the Payout Ratio.OBCI Dividend Payout.PayoutRetained Earnings

OCEAN BIO-CHEM INC

NASDAQ:OBCI (8/8/2022, 8:00:02 PM)

After market: 13.07 +0.04 (+0.31%)

13.03

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)05-27 2022-05-27/bmo
Earnings (Next)08-30 2022-08-30/bmo
Inst Owners0.9%
Inst Owner Change-89.22%
Ins Owners61.67%
Ins Owner Change0%
Market Cap123.91M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.23%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP15.89%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.89
Fwd PE N/A
P/S 1.94
P/FCF N/A
P/OCF N/A
P/B 2.56
P/tB N/A
EV/EBITDA 10.52
EPS(TTM)0.82
EY6.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.72
BVpS5.09
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.52
Profitability
Industry RankSector Rank
ROA 12.58%
ROE 16.11%
ROCE N/A
ROIC 13.99%
ROICexc N/A
ROICexgc 14.32%
OM 15.74%
PM (TTM) 12.2%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.74
Quick Ratio 4.14
Altman-Z 8.61
F-Score3
WACC7.29%
ROIC/WACC1.92
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3Y43.4%
EPS 5Y30.75%
EPS Q2Q%-31.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y15.44%
Revenue growth 5Y12.17%
Sales Q2Q%-2.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A